Themis Medicare Limited Approves Un-Audited Results for Quarter Ended Sep 2025
Themis Medicare Limited's board approves unaudited standalone and consolidated financial results for the quarter ended September 30, 2025. Standalone revenue is ₹7,799.41 Lakhs with a loss of ₹535.55 Lakhs. The board also resolved to withdraw the amalgamation scheme.
The financial results indicate a loss for the quarter, and the withdrawal of the amalgamation scheme could have strategic implications for the company's future direction.
The announcement primarily contains financial results and updates on corporate decisions, without strong positive or negative indicators.
* The Board of Directors approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2025. * Standalone Financial Results for the quarter ended 30th September 2025 (Unaudited): * Revenue from Operations (Net): ₹7,799.41 Lakhs * Total Income: ₹8,123.05 Lakhs * Profit/(Loss) before tax: ₹(519.06) Lakhs * Profit/ (Loss) for the Period: ₹(535.55) Lakhs * Consolidated Financial Results for the quarter ended 30th September 2025 (Unaudited): * Revenue from Operations (Net): ₹7,799.41 Lakhs * Total Income: ₹8,123.05 Lakhs * Profit/ (Loss) before tax: ₹(345.07) Lakhs * Profit/ (Loss) for the Period: ₹(361.56) Lakhs * The Board of Directors of GTBL resolved not to proceed with the proposed merger. In alignment with this decision, the Board of Directors of the Company has resolved to withdraw the said Scheme of Amalgamation. * The company received an approval for struck off M/s. Carpo Medicals Limited (UK), a wholly owned subsidiary company.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.